Prognostic value of the six-minute walk test in end-stage renal disease life expectancy: a prospective cohort study

• Autor(a) principal: Kohl, Leandro de Moraes
• Data de Publicação: 2012
• Outros Autores: Signori, Luis Ulisses, Ribeiro, Rodrigo Antonini, Silva, Antônio Marcos Vargas da, Moreira, Paulo Ricardo, Dipp, Thiago, Sbruzzi, Graciele, Lukrafka, Janice Luisa, Plentz, Rodrigo Della Méa
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da FURG (RI FURG)
• Texto Completo: http://repositorio.furg.br/handle/1/3106; http://dx.doi.org/10.6061/clinics/2012(06)06
• topic: Exercise test; Kidney failure; Chronic; Prognosis; Survival analysis

OBJECTIVES: The six-minute walk test has been widely used to evaluate functional capacity and predict mortality in several populations. Thus, the aim of this study was to evaluate the prognostic value of the six-minute walk test for the life expectancy of end-stage renal disease patients. METHODS: Patients over 18 years old who underwent hemodialysis for at least six months were included. Patients with hemodynamic instability, smoking, chronic obstructive pulmonary disease, physical incapacity and acute myocardial stroke in the preceding three months were excluded. RESULTS: Fifty-two patients (54% males; 36¡11 years old) were followed for 144 months. The distance walked in the six-minute walk test was a survival predictor for end-stage renal disease patients. In the multivariate analysis, for each 100 meters walked with a 100-meter increment, the hazard ratio was 0.53, with a 95% confidence interval of 0.37-0.74. There was a positive correlation between the distance walked in the six-minute walk test and peak oxygen consumption (r = 0.508). In the multivariate analysis, each year of dialysis treatment represented a 10% increase in death probability; in the severity index analysis, each point on the scale represented an 11% increase in the death risk. CONCLUSIONS: We observed that survival increased approximately 5% for every 100 meters walked in the sixminute walk test, demonstrating that the test is a viable option for evaluating the functional capacity in patients with end-stage renal disease.